Celestino Sardu
Overview
Explore the profile of Celestino Sardu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
156
Citations
4465
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cozzolino D, Nevola R, Ruggiero A, Romano C, Umano G, Aitella E, et al.
J Cardiovasc Dev Dis
. 2025 Feb;
12(2).
PMID: 39997510
Background: To date, little is known about correlations between liver dysfunction and circulatory and cardiac abnormalities (e.g.,: mitral valve, MV) in patients with chronic liver disease (CLD). This study aimed...
2.
Caturano A, Rocco M, Tagliaferri G, Piacevole A, Nilo D, Lorenzo G, et al.
Antioxidants (Basel)
. 2025 Jan;
14(1).
PMID: 39857406
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder that significantly increases the risk of cardiovascular disease, which is the leading cause of morbidity and mortality among diabetic patients....
3.
Caturano A, Galiero R, Rocco M, Tagliaferri G, Piacevole A, Nilo D, et al.
Biomolecules
. 2024 Nov;
14(11).
PMID: 39595570
Chronic kidney disease (CKD) represents a significant global health challenge, affecting millions of individuals and leading to substantial morbidity and mortality. This review aims to explore the epidemiology, cardiovascular complications,...
4.
Caturano A, di Martino A, Albanese G, Coppola C, Russo V, Koudelkova K, et al.
Acta Diabetol
. 2024 Nov;
PMID: 39527295
Background: Orthotopic liver transplantation (OLT) has greatly improved short-term survival for end-stage liver disease. However, cardiovascular events (CVE) still pose a significant threat to long-term post-transplant health. Aim of this...
5.
Caturano A, Vetrano E, Galiero R, Sardu C, Rinaldi L, Russo V, et al.
Int J Mol Sci
. 2024 Sep;
25(18).
PMID: 39337658
The insulin-heart axis plays a pivotal role in the pathophysiology of cardiovascular disease (CVD) in insulin-resistant states, including type 2 diabetes mellitus. Insulin resistance disrupts glucose and lipid metabolism, leading...
6.
Caturano A, Galiero R, Rocco M, Tagliaferri G, Piacevole A, Nilo D, et al.
Biomedicines
. 2024 Sep;
12(9).
PMID: 39335551
Type 2 diabetes mellitus (T2DM) is a prevalent chronic metabolic disorder characterized by insulin resistance and progressive beta cell dysfunction, presenting substantial global health and economic challenges. This review explores...
7.
Caturano A, Galiero R, Vetrano E, Sardu C, Rinaldi L, Russo V, et al.
Int J Mol Sci
. 2024 Aug;
25(15).
PMID: 39125938
Insulin signaling is vital for regulating cellular metabolism, growth, and survival pathways, particularly in tissues such as adipose, skeletal muscle, liver, and brain. Its role in the heart, however, is...
8.
Caturano A, Russo V, Monda M, Sardu C, Marfella R, Sasso F
J Cardiovasc Pharmacol
. 2024 Aug;
84(5):493-495.
PMID: 39115821
No abstract available.
9.
Minutolo R, Simeon V, De Nicola L, Chiodini P, Galiero R, Rinaldi L, et al.
Cardiovasc Diabetol
. 2024 Aug;
23(1):285.
PMID: 39103870
Objective: Women with type 2 diabetes experience higher cardiovascular and mortality risk than men possibly because of a sub-optimal cardio-protective treatment. We evaluated whether an intensive multifactorial therapy (MT) produces...
10.
Caturano A, Vetrano E, Galiero R, Salvatore T, Docimo G, Epifani R, et al.
Rev Cardiovasc Med
. 2024 Jul;
23(5):165.
PMID: 39077592
Cardiac hypertrophy develops in response to increased workload to reduce ventricular wall stress and maintain function and efficiency. Pathological hypertrophy can be adaptive at the beginning. However, if the stimulus...